| Measure Code | Measure Title | Performance Rate | Patient Count | Star Value | Five Star Benchmark | Collection Type |
|---|---|---|---|---|---|---|
| IA_EC_CC_1 | Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop | |||||
| IA_EC_PSPA_16 | Use of decision support and standardized treatment protocols | |||||
| IA_EC_PM_16 | Implementation of medication management practice improvements | |||||
| IA_EC_PSPA_21 | Implementation of fall screening and assessment programs | |||||
| MIPS_EC_005_overall | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) | 86 | 81 | EHR | ||
| MIPS_EC_001_overall | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | 47 | 198 | EHR | ||
| MIPS_EC_008_overall | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) | 93 | 82 | EHR | ||
| MIPS_EC_007_overall | Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) | 92 | 91 | EHR | ||
| MIPS_EC_110_overall | Preventive Care and Screening: Influenza Immunization | 88 | 628 | 5 | 85 | EHR |
| MIPS_EC_119_overall | Diabetes: Medical Attention for Nephropathy | 84 | 198 | 4 | 100 | EHR |
| MIPS_EC_236_overall | Controlling High Blood Pressure | 71 | 720 | EHR | ||
| MIPS_EC_318_overall | Falls: Screening for Future Fall Risk | 92 | 598 | 4 | 100 | EHR |
| MIPS_EC_374_overall | Closing the Referral Loop: Receipt of Specialist Report | 17 | 63 | 1 | 88 | EHR |